Quintiles IMS Holdings Inc (Q) EPS Estimated At $1.03

July 18, 2017 - By Darrin Black

 Quintiles IMS Holdings Inc (Q) EPS Estimated At $1.03
Investors sentiment increased to 1.75 in Q4 2016. Its up 1.00, from 0.75 in 2016Q3. It is positive, as 39 investors sold Quintiles IMS Holdings Inc shares while 93 reduced holdings. 85 funds opened positions while 146 raised stakes. 216.20 million shares or 97.25% more from 109.60 million shares in 2016Q3 were reported.
Old Mutual Glob (Uk) Ltd owns 4,900 shares for 0.01% of their portfolio. Andra Ap stated it has 0.1% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). Massachusetts Fincl Serv Communications Ma has invested 0.02% in Quintiles IMS Holdings Inc (NYSE:Q). Aperio Gp owns 0.03% invested in Quintiles IMS Holdings Inc (NYSE:Q) for 54,130 shares. Farallon Management Limited Liability Corporation accumulated 3.63 million shares. Cwm Ltd Llc reported 0% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). Invesco Limited reported 98,630 shares. Goldman Sachs Grp accumulated 0.04% or 2.09M shares. Blackrock Institutional Trust Na has 0.04% invested in Quintiles IMS Holdings Inc (NYSE:Q) for 3.73M shares. Blackrock Inv Lc, New Jersey-based fund reported 91,068 shares. Bremer Trust Natl Association reported 0.06% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). State Of Wisconsin Board, a Wisconsin-based fund reported 76,841 shares. Tudor Investment Et Al holds 0.02% or 11,600 shares in its portfolio. Aqr Capital Mgmt Ltd Liability owns 779,228 shares for 0.08% of their portfolio. 1.01M are owned by Parametric Port Associates Ltd.

Analysts expect Quintiles IMS Holdings Inc (NYSE:Q) to report $1.03 EPS on July, 26.They anticipate $0.10 EPS change or 10.75 % from last quarter’s $0.93 EPS. Q’s profit would be $222.74 million giving it 21.86 P/E if the $1.03 EPS is correct. After having $1.01 EPS previously, Quintiles IMS Holdings Inc’s analysts see 1.98 % EPS growth. The stock increased 0.78% or $0.7 during the last trading session, reaching $90.08. About 958,313 shares traded or 0.41% up from the average. Quintiles IMS Holdings Inc (NYSE:Q) has risen 27.93% since July 18, 2016 and is uptrending. It has outperformed by 11.23% the S&P500.

Quintiles IMS Holdings Inc (NYSE:Q) Ratings Coverage

Among 18 analysts covering Quintiles Transnational (NYSE:Q), 5 have Buy rating, 0 Sell and 13 Hold. Therefore 28% are positive. Quintiles Transnational had 36 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, September 4, the company rating was downgraded by Zacks. On Friday, February 3 the stock rating was downgraded by Deutsche Bank to “Hold”. As per Wednesday, October 5, the company rating was initiated by Goldman Sachs. As per Friday, February 12, the company rating was upgraded by Deutsche Bank. Jefferies maintained the stock with “Hold” rating in Thursday, June 29 report. Robert W. Baird upgraded the stock to “Neutral” rating in Friday, July 7 report. The stock of Quintiles IMS Holdings Inc (NYSE:Q) has “Neutral” rating given on Friday, December 16 by Goldman Sachs. The firm has “Buy” rating by Argus Research given on Thursday, July 30. The rating was downgraded by Wells Fargo to “Market Perform” on Thursday, May 12. Credit Suisse reinitiated the shares of Q in report on Friday, August 14 with “Outperform” rating.

Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The company has market cap of $19.48 billion. The Firm operates through divisions, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. It has a 81.66 P/E ratio. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

More important recent Quintiles IMS Holdings Inc (NYSE:Q) news were published by: Nasdaq.com which released: “Q Crosses Above Average Analyst Target” on June 20, 2017, also Seekingalpha.com published article titled: “Quintiles IMS: A Novel Way To Invest In Biopharma”, Reuters.com published: “Quintiles IMS explores sale of contract sales business: sources” on June 21, 2017. More interesting news about Quintiles IMS Holdings Inc (NYSE:Q) was released by: Prnewswire.com and their article: “Today’s Research Report Coverage on Medical Labs Stocks — Agilent …” with publication date: July 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.